# SYMBIOTEC share price, delivery % and history — SYMBIOTEC

> Delivery percentage for SYMBIOTEC (SYMBIOTEC) against its own history, with 21 sessions of split-adjusted NSE data from 2026 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/SYMBIOTEC

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 1,176.75 INR (2.84% on the day), 2026-09-30
- Delivery: 35.85% of volume taken to demat (20-day average 29.63%)
- Volume: 20.16L shares, turnover ₹237.3Cr
- Relative volume: 1.04× of its own 20-day average

## Technicals

- RSI(14): 59.68
- ATR(14): 67.96
- SMA 50: —, SMA 200: —
- 52-week range: — – — (— from the high)

## Performance

- 1 week 10.81%, 1 month —, 3 months —
- 6 months —, 1 year —

## Delivery percentage

- Latest: 35.85% (2026-09-30)
- 20-day average: 29.63%
- 1-year average: 29.71%
- Percentile against its own history: 90th
- Range: 14.38% – 46.72% across 21 sessions with a reading

Over the last 20 sessions SYMBIOTEC settled 29.6% of its traded quantity, which is ordinary for an NSE equity.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 7,561.3 crore
- P/E (TTM): — — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): — INR, split-adjusted to match the price series
- Revenue growth: — YoY, — QoQ
- Profit growth: — YoY, — QoQ

## Quarterly results

Last 1 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2026-06-30 | 218.2 | 201 | 17.5 | 14.1 | 2.24 | 6.45% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-08-31:

- Promoter: 33.28%
- Public: 66.72%
- FII: 21.08%, DII: 27.52%
- Promoter shares pledged: 0%

## Recent filings

- 2026-09-21: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_195108_21092026185235_iXBRL_WEB.html
- 2026-09-01: shareholding for 2026-08-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1719885_01092026053247_WEB.xml

Dated by the day the company broadcast the filing. 2 events are indexed for this instrument.

## About the instrument

- Listed: 2026-09-01 — latest session 2026-09-30 (21 sessions)
- ISIN: INE899I01028
- Series: EQ
- Liquidity rank: #126 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)
- [CIPLA](https://patternsradar.com/s/CIPLA.md) — Cipla Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/SYMBIOTEC.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.